Natixis’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Natixis’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,553	Closed	-$22K	–	1313
2017 Q3	$22K	Buy	+14,553	New	+$24.4K	﹤0.01%	1238

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Natixis's CVRS Position: Q4 2017 in Review

Natixis sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2017, closing a stake of 14,553 shares — an estimated $22K sold.

Natixis first reported a position in CVRS in Q3 2017 and held it in 1 quarter. The position peaked at $22K in Q3 2017. 64 funds tracked by Wall St. Rank hold CVRS as of Q4 2017.

Natixis reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2017 after selling out during the quarter.
Natixis sold 14,553 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2017, an estimated $22K.
Natixis first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2017 and held it in 1 quarter.
Natixis's CORINDUS VASCULAR ROBOTICS, INC position peaked at $22K in Q3 2017.
64 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2017.

Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.